YK11 10mg
YK11 is presented in the ORYVION catalog as a tablet formulation containing 10mg of YK11 per tablet, supplied in containers of 50 tablets. YK11 is an experimental steroidal compound studied as a partial androgen receptor agonist and selective androgen receptor modulator (SARM).
Its pharmacological activity has been investigated in laboratory models involving androgen-dependent signaling and muscle cell differentiation. A study in cultured mouse muscle cells observed increased follistatin expression associated with myogenic differentiation. These findings do not establish that YK11 inhibits myostatin or increases muscle growth in humans.
Product Specifications:
Commercial name: YK11
Listed compound: YK11
Declared strength: 10mg per tablet
Format: Tablets
Package contents: 50 tablets
Important Note:
YK11’s safety, effectiveness, and long-term effects in humans have not been established. Available evidence is insufficient to characterize its specific hepatic, cardiovascular, hormonal, and reproductive risks.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.